PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
March 22, 2026Current Cancer Drug Targets

Next-Generation Precision Oncology in Prostate Cancer: Synergistic Liquid Biopsy, mpMRI, and AI-Guided Multi-Omics Strategies

View Full Paper
Ask AI
Bookmark
Share

Authors

YCY. ChenMLMeiting LaoGLGuizhen Lyu

Discussion

Loading...

Member takes

Overview

Review highlights liquid biopsy, genomics, and AI in prostate cancer management, improving risk stratification and reducing metastasis.

Key Points

  • Evaluate advanced diagnostic methods in prostate cancer, focusing on multi-omics and AI integration.
  • Review of current tools in prostate cancer diagnosis and management
  • Assessment of multi-omics approaches including genomics and liquid biopsy
  • Evaluation of AI applications in imaging and treatment decision-making.
  • Integrated multi-omics improve diagnosis accuracy in prostate cancer.
  • AI enhances risk stratification and reduces unnecessary biopsies.
  • Circulating tumor DNA assays provide higher sensitivity than traditional PSA testing.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/69bf3924c7b3c90b18b437e5https://doi.org/10.2174/0115680096451172260202074302
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers2025 · 5 citations
  2. 2From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging2026 · 1 citations
  3. 3Integrative advances in biomarker-driven prostate cancer management from genomic discovery to precision oncology2026
  4. 4Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligence2026 · 2 citations
  5. 5Advances in imaging and artificial intelligence for precision diagnosis and biopsy guidance in prostate cancer2025 · 3 citations